This group of activators comprises a diverse range of molecules that influence SMYD1's methyltransferase function, often by modulating its activity through various signaling pathways and co-factor interactions. Many SMYD1 activators act as signaling molecule analogs or agonists that engage specific cellular pathways. For instance, compounds like Forskolin and 8-Bromo-cGMP activate SMYD1 through the elevation of intracellular cAMP and cGMP levels, respectively. These secondary messengers trigger cascades of intracellular events that ultimately culminate in the activation of SMYD1, facilitating its methyltransferase activity. Similarly, Retinoic Acid and Triiodothyronine (T3) activate SMYD1 through their interaction with nuclear receptors, such as Retinoic Acid Receptors (RARs) and Thyroid Hormone Receptors (THRs). These interactions lead to the upregulation of SMYD1 expression, thereby increasing the availability of the enzyme and enhancing its methyltransferase function.
One notable subgroup of SMYD1 activators includes signaling molecule analogs. For example, Forskolin, found in the Indian coleus plant, stimulates adenylate cyclase activity in cells, leading to an increase in cyclic adenosine monophosphate (cAMP) levels. Elevated cAMP subsequently activates protein kinase A (PKA), initiating a cascade of intracellular events. In turn, PKA can phosphorylate SMYD1, resulting in its activation and enhanced methyltransferase activity. Similarly, 8-Bromo-cGMP, a cyclic guanosine monophosphate (cGMP) analog, triggers cGMP-dependent signaling pathways, ultimately activating SMYD1. These compounds exemplify the interplay between small molecules and cellular signaling networks in regulating SMYD1.
In summary, SMYD1 activators represent a chemically diverse group of compounds that exert their effects through various cellular signaling pathways and interactions with specific receptors or co-factors. By modulating SMYD1 activity, these compounds play a vital role in influencing epigenetic regulation and gene expression, offering insights into cellular processes and molecular mechanisms that govern gene transcription and chromatin modification.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activates SMYD1 by enhancing the availability of adenosyl methionine (SAM), a co-substrate required for SMYD1's methyltransferase activity. Adenosine indirectly supports SMYD1's methyltransferase function. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
SAM serves as a co-substrate for SMYD1, providing the methyl groups essential for its methyltransferase activity. SAM is directly involved in the methylation of SMYD1 substrates. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Activates SMYD1 through cAMP-dependent signaling pathways. db-cAMP triggers signaling cascades that ultimately lead to the activation of SMYD1 and its methyltransferase activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates SMYD1 through protein kinase C (PKC)-dependent signaling pathways. TPA stimulates PKC, which then activates SMYD1, promoting its methyltransferase function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates SMYD1 through adenylate cyclase activation. Forskolin elevates cellular cAMP levels, which in turn activate SMYD1 through cAMP-dependent pathways, leading to increased methyltransferase activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Activates SMYD1 through retinoic acid receptor (RAR) signaling. Retinoic acid binds to RAR, which regulates SMYD1 gene expression and consequently increases SMYD1 protein levels and methyltransferase activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Activates SMYD1 through glucocorticoid receptor (GR) signaling. Dexamethasone binds to GR, which can lead to the upregulation of SMYD1 expression, enhancing its methyltransferase function. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
Activates SMYD1 through cyclic guanosine monophosphate (cGMP)-dependent pathways. 8-Bromo-cGMP triggers cGMP signaling cascades, ultimately leading to the activation of SMYD1 and its methyltransferase activity. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
Activates SMYD1 through thyroid hormone receptor (THR) signaling. T3 binds to THR, which regulates SMYD1 gene expression, increasing SMYD1 protein levels and methyltransferase activity. | ||||||